| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/19/2007 | CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | CA2625219A1 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | CA2624307A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 04/19/2007 | CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3 |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | CA2623202A1 Hydrazide compound and pesticidal use of the same |
| 04/19/2007 | CA2622755A1 Mek inhibitors and methods of their use |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/18/2007 | EP1775295A1 Vanilloid receptor ligands and their use in treatments |
| 04/18/2007 | EP1775294A1 Phenyl-furyl-methyl-thiazolidine-2,4-dione or phenyl-thienyl-methyl-thiazolidine-2,4-dione compounds; use for stimulating or inducing keratin fibre growth and/or slowing down their loss; compostions thereof |
| 04/18/2007 | EP1773868A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease |
| 04/18/2007 | EP1773835A2 Pyrido-pyrido-pyrimidine derivatives, preparation thereof, therapeutic use thereof for treating cancer |
| 04/18/2007 | EP1773828A1 Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 04/18/2007 | EP1773827A1 Benzothiazole derivatives |
| 04/18/2007 | EP1773826A2 C-met modulators and method of use |
| 04/18/2007 | EP1773822A2 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 04/18/2007 | EP1773817A1 Substituted aryl-amine derivatives and methods of use |
| 04/18/2007 | EP1773810A1 New 4-benzylidene-piperidin derivatives |
| 04/18/2007 | EP1773797A2 Aromatic compounds |
| 04/18/2007 | EP1773786A2 Five-membered heterocycles useful as serine protease inhibitors |
| 04/18/2007 | EP1773784A2 Anti-inflammatory medicaments |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 04/18/2007 | EP1773347A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/18/2007 | EP1773337A2 Modulators of nuclear receptors |
| 04/18/2007 | EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 04/18/2007 | EP1476162B1 Controlled synthesis of ziprasidone |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
| 04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
| 04/18/2007 | CN1950369A Novel benzothiazoles and the use thereof as medicaments |
| 04/18/2007 | CN1950365A Indolyl derivatives as liver-X-receptor modulators |
| 04/18/2007 | CN1950357A Imidazole derivatives used as TAFIA inhibitors |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950349A 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 04/18/2007 | CN1950348A Substituted morpholine compounds for the treatment of central nervous system disorders |
| 04/18/2007 | CN1950345A Morpholinylanilinoquinazoline derivatives for use as antiviral agents |
| 04/18/2007 | CN1950343A Basic amine compound and use thereof |
| 04/18/2007 | CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 04/18/2007 | CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof |
| 04/18/2007 | CN1948307A Preparation method of 5-(2-pyridyl)-2-sulfhydryl-1,3,4-thiadiazole |
| 04/18/2007 | CN1948305A New dioxo morpholine kind compound, its preparation method and use |
| 04/18/2007 | CN1948286A Salt of carboxylic acid containing N-substituted succinimide thio group and unvulcanized rubber composition containing the same |
| 04/18/2007 | CN1310912C 5-[4-[2(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salt |
| 04/18/2007 | CN1310911C Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders |
| 04/18/2007 | CN1310907C Heterocyclic compound and antitumour agent containing the same as active ingredient |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205413 Comprises formamide solvent; for treatment of HIV/inhibiting proteases; crystal structure; kits |
| 04/17/2007 | US7205410 Heterocyclic amines used as antiemetics for prophylaxis of irritable bowel syndrome constipation, diarrhea, dyspepsia, nausea or vomiting |
| 04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
| 04/17/2007 | US7205408 Therapy for bacteria infections in mammals |
| 04/17/2007 | US7205384 Process for preparing peptidyl heterocyclic ketone derivatives |
| 04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
| 04/17/2007 | US7205328 Aids viricide |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205322 Thiazolidine compounds as calcium sensing receptor modulators |
| 04/17/2007 | US7205318 Inhibitors of trypsin-like serine protease enzymes; for use as anticoagulant agents for therapy of thromboembolic disorders |
| 04/17/2007 | US7205317 Pain management |
| 04/17/2007 | US7205316 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 04/17/2007 | US7205313 Central nervous system disorders; analgesics; headaches |
| 04/17/2007 | US7205312 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |
| 04/17/2007 | US7205309 Obesity therapy; administering orlistat |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205301 Microbiocidal N-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
| 04/17/2007 | US7205295 such as 4-(4-tert-Butyl-benzyl)-6-(4-oxo-2-thioxo-thiazolidin-5-ylidenemethyl)-4H-1,4-benzoxazin-3-one; phosphoinositide-3-kinases (PI3Ks); for treatment/prevention of inflammatory diseases, cardiovascular diseases, and cancers |
| 04/17/2007 | CA2407759C Substituted phenylacetamides and their use as glucokinase activators |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2299300C Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors |
| 04/17/2007 | CA2295792C A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/17/2007 | CA2202775C Method for treating anxiety |
| 04/12/2007 | WO2007041616A1 Piperazine amidines as antiviral agents |
| 04/12/2007 | WO2007041324A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007041270A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2007 | WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/12/2007 | WO2007040280A1 Cyclic amine compound and pest control agent |
| 04/12/2007 | WO2007040208A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
| 04/12/2007 | WO2007040166A1 Novel fused pyrrole derivative |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039404A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
| 04/12/2007 | WO2007039175A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039171A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039170A1 Antagonists of topoisomerase activity and their use in inhibiting pathological conditions |
| 04/12/2007 | WO2007039146A1 4-carboxy pyrazole derivatives as anti-viral agents |
| 04/12/2007 | WO2007039145A1 C (2) -heteroarylmethyl-c (4) -pyrazinyl-2-yl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus |
| 04/12/2007 | WO2007039144A1 Pyrrolidine derivatives for treating viral infections |
| 04/12/2007 | WO2007039143A1 C (2) -heteroarylmethyl-c (4) -pyrazin-2-yl acyl pyrrolidine compounds and their user for treating viral infections, especially hepatitics c (hcv) |
| 04/12/2007 | WO2007039142A1 C (2) -heteroarylmethyl-c (4) -methoxymethyl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus |
| 04/12/2007 | WO2007038865A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | WO2007022415A3 Substituted 2-aminothiazoles for treating neurodegenerative diseases |
| 04/12/2007 | WO2007020213A3 Thiazolyl piperidine derivatives useful as h3 receptor modulators |